Cell therapy of brain stroke

Area of Science:

• Neuroscience
• Regenerative Medicine
• Hematology

Background:

• Brain stroke, a leading cause of disability, often results in long-term functional deficits.
• Current treatments for stroke consequences have limitations in restoring lost function.
• Cell-based therapies offer a potential avenue for neural repair and functional recovery.

Purpose of the Study:

• To evaluate the safety and efficacy of subarachnoidally transplanted immature cells for treating brain stroke consequences.
• To assess the impact of cell therapy on functional activity in stroke patients.

Main Methods:

• Subarachnoid transplantation of cell suspension derived from immature nervous and hemopoietic tissues.
• Inclusion of 10 patients with brain stroke consequences.
• Comparison with a clinically comparable control group.

Main Results:

• Clinical effects of varying degrees were observed in all treated patients.
• Significant increase in functional activity was noted six months post-cell therapy compared to the control group.
• No serious complications were reported during or after the cell therapy procedure.

Conclusions:

• Cell therapy, using immature nervous and hemopoietic cells, demonstrated a positive clinical effect in patients with brain stroke consequences.
• The treatment appears to be relatively safe, with no observed serious complications.
• Cell therapy holds promise as an effective therapeutic strategy for managing the aftermath of brain strokes.